Dantrolene prodrugs and methods of their use
US11352347B2 · kind B2 · utility
2Cited by
3References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2018 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Oct 19, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure is directed to dantrolene prodrugs, compositions thereof, and methods of their use in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.